About Hi-Tech
Hi-Tech is a Healthcare company based in Amityville (United States) founded in 1983, and was acquired by Akorn in August 2013. Generic, branded, and OTC pharmaceutical products are manufactured. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified.
Company details
Hi-Tech was established in 1983 in Amityville, United States, within the pharmaceutical sector. Operations centered on producing generic, branded, and OTC items, with emphasis on liquid and semi-solid dosage forms such as solutions, suspensions, creams, nasal sprays, gels, ophthalmics, and ointments. A dedicated healthcare division managed OTC products, while subsidiary ECR Pharmaceuticals oversaw branded formulations. Acquisition by Akorn Pharma took place in 2013.
- Headquarters Amityville, United States
- Stage Acquired
- SectorsHealthcare
- Website hitechpharm.com
- Acquired by Akorn (Aug 2013)
Investors in Hi-Tech
Hi-Tech has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Akorn.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Injectable and ophthalmic pharmaceutical products were manufactured across therapeutic areas. | 1948 | akorn.com | Lake, United States |
Investor details for Hi-Tech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Hi-Tech
3 dated milestones of Hi-Tech across 30 years, from founding to its latest funding, stage changes and deals.
- Founded Hi-Tech is founded.
- IPO Lists on the stock exchange (IPO).
- Exit Acquired by Akorn.
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Hi-Tech (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | USD 3.02 B | 8,300 | ||
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Hi-Tech
Hi-Tech was founded in 1983.
Hi-Tech is headquartered in Amityville, United States. It is registered at Amityville, New York, United States.
Hi-Tech was established in 1983 in Amityville, United States, within the pharmaceutical sector. Operations centered on producing generic, branded, and OTC items, with emphasis on liquid and semi-solid dosage forms such as solutions, suspensions, creams, nasal sprays, gels, ophthalmics, and ointments. A dedicated healthcare division managed OTC products, while subsidiary ECR Pharmaceuticals oversaw branded formulations. Acquisition by Akorn Pharma took place in 2013.
Hi-Tech has 1 investor. Key investors include Akorn.
Yes. Hi-Tech was acquired by Akorn in August 2013.